Pharmacokinetic/Pharmacodynamic Modeling to Support A Lack of Effect of Tafenoquine (TQ) on the QT Interval in a Thorough QT (TQT) Study

被引：0
|
作者：
Patel, Bela [1 ]
Miller, Ann [1 ]
Tenero, David [1 ]
Green, Justin [2 ]
机构：
[1] GlaxoSmithKline, Clin Pharmacol Modeling & Simulat, King Of Prussia, PA USA
[2] GlaxoSmithKline, Dis Dev World, Clin Dev, Stevenage, Herts, England
来源：
JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS | 2014年 / 41卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
M-003
引用
收藏
页码：S8 / S8
页数：1
相关论文
共 50 条
  • [1] The sodium glucose cotransporter 2 inhibitor empagliflozin does not prolong QT interval in a thorough QT (TQT) study
    Arne Ring
    Tobias Brand
    Sreeraj Macha
    Kerstin Breithaupt-Groegler
    Gudrun Simons
    Beate Walter
    Hans J Woerle
    Uli C Broedl
    Cardiovascular Diabetology, 12
  • [2] The sodium glucose cotransporter 2 inhibitor empagliflozin does not prolong QT interval in a thorough QT (TQT) study
    Ring, Arne
    Brand, Tobias
    Macha, Sreeraj
    Breithaupt-Groegler, Kerstin
    Simons, Gudrun
    Walter, Beate
    Woerle, Hans J.
    Broedl, Uli C.
    CARDIOVASCULAR DIABETOLOGY, 2013, 12
  • [3] Assay sensitivity in "Hybrid thorough QT/QTc (TQT)" study
    Huang, Dalong Patrick
    Chen, Janell
    Dang, Qianyu
    Tsong, Yi
    JOURNAL OF BIOPHARMACEUTICAL STATISTICS, 2019, 29 (02) : 378 - 384
  • [4] Levetiracetam thorough QT study: lack of proarrhythmic effect
    Hulhoven, R.
    Rosillon, D.
    Bridson, W.
    Salas, E.
    Chen, D.
    Watanabe, S.
    Meesus, M.
    Stockis, A.
    EPILEPSIA, 2007, 48 : 64 - 65
  • [5] Brivaracetam thorough QT study: Lack of proarrhythmic effect
    Rosillon, D.
    Astruc, B.
    Bendahmane, S.
    Hulhoven, R.
    Meeus, M. A.
    Troenaru, M.
    Watanabe, S.
    Stockis, A.
    EPILEPSIA, 2007, 48 : 329 - 329
  • [6] Levetiracetam thorough QT study: Lack of proarrhythmic effect
    Hulhoven, Reginald
    Rosillon, D.
    Bridson, W.
    Salas, E.
    Chen, D.
    Watanabe, S.
    Meeus, M. A.
    Stockis, A.
    EPILEPSIA, 2007, 48 : 361 - 361
  • [7] Prediction of Thorough QT Trials based on Population Pharmacokinetic: Pharmacodynamic Analysis of Phase I Study QT Data
    Trame, Mirjam N.
    Vik, Torbjorn
    Hamren, Ulrika Wahlby
    Henriksson, Karin M.
    Friberg, Lena E.
    JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS, 2013, 40 : S78 - S79
  • [8] The "Thorough QT study": A valid paradigm to test new algorithms for QT interval measurements?
    Badilini, Fabio
    JOURNAL OF ELECTROCARDIOLOGY, 2013, 46 (02) : 126 - 127
  • [9] Sex differences in QT interval variability and implication on sample size of thorough QT study
    Zhang, Lu
    Smith, Brian P.
    DRUG INFORMATION JOURNAL, 2007, 41 (05): : 619 - 627
  • [10] Population Pharmacokinetic/Pharmacodynamic Evaluation of the Effect of Glasdegib on QT Interval in Healthy Adult Subjects
    Masters, Joanna C.
    Shaik, Naveed
    JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS, 2018, 45 : S58 - S58
12345